Autosomal recessive spinal muscular atrophy with respiratory distress type 1 (SMARD1), recently referred to as distal spinal muscular atrophy 1 (DSMA1; MIM#604320) and also known as distal hereditary motor neuropathy type 6 (dHMN6 or HMN6), results from mutations in the IGHMBP2 gene on chromosome 11q13.3 encoding the immunoglobulin µ-binding protein 2. In contrast to the infantile spinal muscular atrophy type 1 (SMA1; Werdnig-Hoffmann disease) with weakness predominantly of proximal muscles and bell-shaped thorax deformities due to intercostal muscle atrophy, infants with distal spinal muscular atrophy 1 usually present with distal muscle weakness, foot deformities, and sudden respiratory failure due to diaphragmatic paralysis that often requires urgent intubation. In this article, the authors review the clinical, neuropathological, and genetic aspects of distal spinal muscular atrophy 1 and discuss differential diagnoses.
Wirth B.An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat.2000;15:228-237.
2.
Rudnik-Schöneborn S., de Visser M., Zerres K.Spinal muscular atrophies. In: Engel AG, Franzini-Armstrong C, eds. Myology, Basic and Clinical. 3rd ed., volume II. New York : McGraw-Hill; 2004:1845-1864.
3.
Mellins RB, Hays AP, Gold AP et al. Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease. Pediatrics. 1974;53:33-40.
4.
Grohmann K., Wienker TF, Saar K., et al. Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21. Am J Hum Genet.1999;65:1459-1462.
5.
Grohmann K., Schuelke M., Diers A., et al. Mutations in the gene encoding immunoglobulin µ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet.2001;29:75-77.
6.
Appleton RE, Hübner C., Grohmann K., Varon R.Congenital peripheral neuropathy presenting as apnoea and respiratory insufficiency: spinal muscular atrophy with respiratory distress type 1 (SMARD1). Dev Med Child Neurol.2004;46:576.
7.
Giannini A., Pinto AM, Rossetti G., et al. Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1. Intensive Care Med.2006;32:1851-1855.
8.
Grohmann K., Varon R., Stolz P., et al. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol.2003;54:719-724.
9.
Guenther UP, Schuelke M., Bertini E., et al. Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1. Hum Genet.2004;115:319-326.
10.
Maystadt I., Zarhrate M., Landrieu P., et al. Allelic heterogeneity of SMARD1 at the IGHMBP2 locus. Hum Mutat.2004;23: 525-526.
11.
Pitt M., Houlden H., Jacobs J., et al. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain. 2003;126:2682-2692.
12.
Rudnik-Schöneborn S., Stolz P., Varon R., et al. Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) . Neuropediatrics. 2004;35:174-182.
13.
Wong VC, Chung BH, Li S., et al. Mutation of gene in spinal muscular atrophy respiratory distress type I. Pediatr Neurol.2006;34:474-477.
14.
Hartley L., Kinali M., Knight R., et al. A congenital myopathy with diaphragmatic weakness not linked to the SMARD1 locus. Neuromuscul Disord. 2007 ;17(2):174-179.
15.
Guenther UP , Varon R., Schlicke M., et al. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat.2007;28:808-815.
16.
Eichholz S. , Kretzschmar B., Tegtmeyer FKSpinal muscular atrophy with respiratory distress type 1 (SMARD1): clinical history and rehabilitation of two 24-hours-home-ventilated children [abstract]. Neuropediatrics. 2004 ;35:82-83.
17.
Cook SA, Johnson KR, Bronson RT, Davisson MTNeuromuscular degeneration (nmd): a mutation on mouse chromosome 19 that causes motor neuron degeneration. Mamm Genome. 1995 ;6: 187-191.
18.
Maddatu TP, Garvey SM, Schroeder DG, et al. Dilated cardiomyopathy in the nmd mouse: transgenic rescue an QTLs that improve cardiac function and survival. Hum Mol Genet.2005;14:3179-3189.
19.
Molnar GM, Crozat A., Kraeft SK, et al. Association of the mammalian helicase MAH with the pre-mRNA splicing complex. Proc Natl Acad Sci USA. 1997;94:7831-7836.
20.
Diers A., Kaczinski M., Grohmann K., et al. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1). Acta Neuropathol.2005;110:289-297.
21.
Grohmann K. , Rossoll W., Kobsar I., et al. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). Hum Mol Genet.2004;13:2031-2042.
22.
Guenther UP , Varon R., Schlicke M., et al. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat.2007;28:808-815.
